These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18783379)

  • 21. Novelty-induced activity-regulated cytoskeletal-associated protein (Arc) expression in frontal cortex requires serotonin 2A receptor activation.
    Santini MA; Klein AB; El-Sayed M; Ratner C; Knudsen GM; Mikkelsen JD; Aznar S
    Neuroscience; 2011 Sep; 190():251-7. PubMed ID: 21664256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects.
    Muguruza C; Moreno JL; Umali A; Callado LF; Meana JJ; González-Maeso J
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):852-64. PubMed ID: 23176747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT2A receptors control body temperature in mice during LPS-induced inflammation via regulation of NO production.
    Voronova IP; Khramova GM; Kulikova EA; Petrovskii DV; Bazovkina DV; Kulikov AV
    Pharmacol Res; 2016 Jan; 103():123-31. PubMed ID: 26621247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
    Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of 5-HT
    Lee KZ; Gonzalez-Rothi EJ
    Respir Physiol Neurobiol; 2017 Oct; 244():51-55. PubMed ID: 28711602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.
    Muntasir HA; Bhuiyan MA; Ishiguro M; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2006 Oct; 102(2):189-95. PubMed ID: 17031071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of 5-HT1B and 5-HT1D receptors in the rat nucleus tractus solitarius: opposing action on neurones that receive an excitatory vagal C-fibre afferent input.
    Jeggo RD; Wang Y; Jordan D; Ramage AG
    Br J Pharmacol; 2007 Apr; 150(8):987-95. PubMed ID: 17339842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors.
    Popa D; Léna C; Fabre V; Prenat C; Gingrich J; Escourrou P; Hamon M; Adrien J
    J Neurosci; 2005 Dec; 25(49):11231-8. PubMed ID: 16339018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes inhibits the DOI-induced head-twitch response in mice.
    Miyata S; Hirano S; Kamei J
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):224-9. PubMed ID: 15290007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
    Pinto W; Battaglia G
    Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction.
    Sipe K; Leventhal L; Burroughs K; Cosmi S; Johnston GH; Deecher DC
    Brain Res; 2004 Dec; 1028(2):191-202. PubMed ID: 15527744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
    Su YA; Si TM; Zhou DF; Guo CM; Wang XD; Yang Y; Shu L; Liang JH
    Eur J Pharmacol; 2007 Jun; 564(1-3):123-30. PubMed ID: 17395179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance of gasping and restoration of eupnea after hypoxia is impaired following blockers of alpha1-adrenergic receptors and serotonin 5-HT2 receptors.
    St-John WM; Leiter JC
    J Appl Physiol (1985); 2008 Mar; 104(3):665-73. PubMed ID: 18162482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of a high-affinity ketanserin binding site at the 5-Hydroxytryptamine(1B) receptor by modification of its carboxy-terminal intracellular portion.
    Wurch T; Palmier C; Pauwels PJ
    Biochem Pharmacol; 2000 May; 59(9):1117-21. PubMed ID: 10704941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin₂A/C receptors mediate the aggressive phenotype of TLX gene knockout mice.
    Juárez P; Valdovinos MG; May ME; Lloyd BP; Couppis MH; Kennedy CH
    Behav Brain Res; 2013 Nov; 256():354-61. PubMed ID: 23933143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.
    Mixcoatl-Zecuatl T; Jolivalt CG
    Br J Pharmacol; 2011 Sep; 164(1):159-69. PubMed ID: 21410686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.